Combination therapy reduces tumor resistance to radiation

June 07, 2007

Radiation is used to treat a variety of tumors and the response of tumors to radiation is dependent on endothelial cell death, which in turn limits oxygen delivery to the tumor, causing hypoxia and tumor cell death. Recently, radiation-induced hypoxia was shown to trigger tumor resistance to radiation via the activation of new blood vessel formation (angiogenesis) through molecules known as HIF-1-regulated cytokines. In a study appearing online on June 7 in advance of publication in the July print issue of the Journal of Clinical Investigation, Claire Magnon and colleagues from Institut Gustave Roussy, France, show that a combination of radiation treatment and the use of angiogenesis inhibitors such as canstatin is able to overcome HIF-1-dependent tumor survival pathways and increases tumor cell death. The authors found that following application of this dual therapy to mice, HIF-1alpha increased the activity of the canstatin-induced tumor apoptotic pathway, which lead to lethal tumor damage. The study demonstrates a crucial role for angiogenesis inhibitors in shifting tumor radioresistance towards tumor apoptosis and suggests that a combination of radiation and angiogenesis inhibitors could potentially be used to overcome HIF-1-dependent tumor radioresistance.
-end-
TITLE: Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch

AUTHOR CONTACT:
Claire Magnon
Mount Sinai School of Medicine, New York, New York, USA.
E-mail: claire.magnon@mssm.edu or clairemagnon@free.fr

View the PDF of this article at: https://www.the-jci.org/article.php?id=30269

JCI Journals

Related Angiogenesis Articles from Brightsurf:

Oncotarget: miR-151a enhances Slug dependent angiogenesis
Volume 11, Issue 23 of @Oncotarget reported that the authors have previously established that mi R-151a functions as an onco-mi R in non-small cell lung cancer cells by inducing partial EMT and enhancing tumor growth.

The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development
In the present study, the research team investigated AEZS-108 induced cytotoxicity and the altered mRNA expression profile of regulatory factors related to angiogenesis and metastasis in LHRH receptor-positive OCM3 cells.

A newly identified mechanism can be targeted to boost angiogenesis
Scientists of the National Center for Cardiovascular Research (CNIC) have discovered a cellular and molecular mechanism that can be exploited to induce productive and sustained angiogenesis in tissues that have become ischemic due to reduced blood supply.

Blood runs deep: Lab blood vessel model sheds light on angiogenesis
Researchers at the University of Tokyo and at CNRS in France revealed the importance of the molecule EGFL7 for angiogenesis and endothelial integrity using an artificially created blood vessel model called a microvessel-on-a-chip.

FDA-approved drug may block resistance to anti-angiogenesis therapy
A Massachusetts General Hospital research team has identified a potential strategy for improving the efficacy of angiogenesis inhibitors, drugs that help fight cancer by blocking the formation of new blood vessels.

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina--the sensory tissue at the back of the eye--using gene-editing techniques with CRISPR-Cas9.

NYU Tandon's 3-D microscopic voyage at SXSW spotlights angiogenesis research
High school seniors accepted to NYU Tandon School of Engineering will receive 3-D cardboard viewers that will take them on a journey to a microscopic, intracellular world -- a virtual reality (VR) game environment where they can watch cells communicate using chemical signals.

Heart bypass without surgery? -- AGGF1 induces therapeutic angiogenesis through autophagy
Coronary artery disease, the number one killer world-wide, restricts and ultimately blocks blood vessels, cutting off oxygen supply to the heart.

Going to 'Wars' against cancer and heart disease
Wars2 was discovered to be involved in angiogenesis -- blood vessel formation, which is important in ensuring that all parts of the body get nutrients to sustain life.

Targeting 2 angiogenesis pathways could improve results of glioblastoma treatment
Two companion papers from Massachusetts General Hospital research teams suggest that targeting multiple angiogenesis pathways simultaneously could help overcome the resistance to anti-angiogenic treatment inevitably developed by the devastating brain tumor glioblastoma.

Read More: Angiogenesis News and Angiogenesis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.